Human Reproduction, Vol 12, 39-44, Copyright © 1997 by Oxford University Press
M Focacci, AJ Quayle, JA Politch and DJ Anderson
Previous studies on antisperm cell-mediated immunity (CMI) have been
confounded by the presence of immunogenic leukocytes in sperm antigen
preparations. In this study we isolated pure populations of viable
spermatozoa on discontinuous Percoll gradients, and utilized sonicated and
cavitated extracts, as well as live motile spermatozoa, to measure cellular
immunity to spermatozoa in vasectomized men, men with proven fertility,
infertile women, fertile women and umbilical cord blood. Using a thymidine
incorporation assay to assess lymphocyte proliferation, nine out of 13
(69%) vasectomized men and five out of 10 (50%) fertile men responded to
sperm extracts. Lymphocyte proliferation to sperm extracts was also
observed in both infertile and fertile women (27 and 50% respectively). In
addition, viable sperm preparations promoted lymphocyte responses in five
out of eight (63%) fertile women, seven out of 11 (63%) healthy men and
four out of 11 (45%) cord blood specimens. Furthermore, four out of 11
(36%) healthy normal men responded to autologous spermatozoa. No
relationship between serum antisperm antibodies, as measured with the
Immunobead test, and sperm CMI was observed in any group. This study
provides evidence that lymphocytes from fertile as well as infertile men
and women and sperm- naive newborn infants proliferate when exposed to
viable spermatozoa or sperm extracts. Thus the lymphocyte proliferation
assay does not appear to be useful in the diagnosis of immunological
infertility, but immunological recognition of spermatozoa may be a common
feature that could have a role in fertility.
ARTICLES
Optimized assay for antisperm cell-mediated immunity
![]()
CiteULike
Connotea
Del.icio.us What's this?